BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 20083694)

  • 21. Buschke-Ollendorff syndrome: a manifestation of a heterozygous nonsense mutation in the LEMD3 gene.
    Gass JK; Hellemans J; Mortier G; Griffiths M; Burrows NP
    J Am Acad Dermatol; 2008 May; 58(5 Suppl 1):S103-4. PubMed ID: 18489034
    [No Abstract]   [Full Text] [Related]  

  • 22. Identification of a Novel Point Mutation in the LEMD3 Gene in an Infant With Buschke-Ollendorff Syndrome.
    Kratzsch J; Mitter D; Ziemer M; Kohlhase J; Voth H
    JAMA Dermatol; 2016 Jul; 152(7):844-5. PubMed ID: 27007781
    [No Abstract]   [Full Text] [Related]  

  • 23. A novel LEMD3 pathogenic variant in a son and mother with osteopoikilosis.
    Elmaoğulları S; Yıldız AE; Demir S; Gürkan H; Uçaktürk SA
    Turk J Pediatr; 2019; 61(4):594-598. PubMed ID: 31990479
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Buschke-Ollendorff syndrome associated with hypertrophic scar formation: a possible role for LEMD3 mutation.
    Korekawa A; Nakano H; Toyomaki Y; Takiyoshi N; Rokunohe D; Akasaka E; Nakajima K; Sawamura D
    Br J Dermatol; 2012 Apr; 166(4):900-3. PubMed ID: 21985280
    [No Abstract]   [Full Text] [Related]  

  • 25. The heterozygous Lemd3 +/GT mouse is not a murine model for osteopoikilosis in humans.
    Dheedene A; Deleye S; Hellemans J; Staelens S; Vandenberghe S; Mortier G
    Calcif Tissue Int; 2009 Dec; 85(6):546-51. PubMed ID: 19862465
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Buschke-Ollendorff syndrome: three generations in a Japanese family.
    Kawamura A; Ochiai T; Tan-Kinoshita M; Suzuki H
    Pediatr Dermatol; 2005; 22(2):133-7. PubMed ID: 15804302
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Modeling-based bone formation transforms trabeculae to cortical bone in the sclerotic areas in Buschke-Ollendorff syndrome. A case study of two females with LEMD3 variants.
    Frost M; Rahbek ET; Ejersted C; Høilund-Carlsen PF; Bygum A; Thomsen JS; Andreasen CM; Andersen TL; Frederiksen AL
    Bone; 2020 Jun; 135():115313. PubMed ID: 32151766
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Novel 4-bp Intronic Deletion (c.1560+5_1560+8del) [corrected] in LEMD3 in a Korean Patient With Osteopoikilosis.
    Yoo IY; Song JS; Ki CS; Kim JW; Cha HS; Min YK
    Ann Lab Med; 2017 Nov; 37(6):540-543. PubMed ID: 28840995
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Depressed indurated plaque with elastorrhexis as a distinctive lesion in Buschke-Ollendorff syndrome.
    Velasco Huici R; Martín JM; Vázquez B; Silva E; Estébanez A; Cuesta A; Ramón D; Monteagudo C
    Pediatr Dermatol; 2020 Mar; 37(2):385-387. PubMed ID: 31943321
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Melorheostosis and Osteopoikilosis: A Review of Clinical Features and Pathogenesis.
    Wordsworth P; Chan M
    Calcif Tissue Int; 2019 May; 104(5):530-543. PubMed ID: 30989250
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ossifying fibroma in Buschke-Ollendorff syndrome.
    Dawson AL; Schulman JM; Jordan RC; North JP
    J Cutan Pathol; 2014 Sep; 41(9):740-4. PubMed ID: 24917176
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Family Buschke-Ollendorff syndrome].
    Vergara A; Isarría MJ; Sánchez-Caminero P; Rodríguez-Peralto JL; Guerra A
    Actas Dermosifiliogr; 2005; 96(1):52-3. PubMed ID: 16476335
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Buschke-Ollendorff syndrome. Connective tissue nevi in osteopoikilosis].
    Bonde CT; Vielfreund L
    Ugeskr Laeger; 2001 Jan; 163(2):170-1. PubMed ID: 11379244
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Buschke-Ollendorff syndrome in a 6-year-old patient: clinical and histopathological aspects of a rare disease.
    Diotallevi F; Simonetti O; Radi G; Martina E; Paolinelli M; Sapigni C; Guanciarossa F; Bianchelli T; Brancorsini D; Offidani A
    Acta Dermatovenerol Alp Pannonica Adriat; 2020 Mar; 29(1):31-33. PubMed ID: 32206820
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Buschke-Ollendorff syndrome.
    Hassikou H; Tabache F; Safi S; Baaj M; Hadri L
    Joint Bone Spine; 2008 Mar; 75(2):212-4. PubMed ID: 18313966
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical considerations in Buschke-Ollendorff syndrome.
    Walpole IR; Manners PJ
    Clin Genet; 1990 Jan; 37(1):59-63. PubMed ID: 2302824
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Buschke-Ollendorff syndrome: inactivating mutation of the LEMD3 gene].
    Dereure O
    Ann Dermatol Venereol; 2005; 132(6-7 Pt 1):593. PubMed ID: 16142115
    [No Abstract]   [Full Text] [Related]  

  • 38. Melorheostosis: a Rare Sclerosing Bone Dysplasia.
    Kotwal A; Clarke BL
    Curr Osteoporos Rep; 2017 Aug; 15(4):335-342. PubMed ID: 28676968
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Buschke-Ollendorff syndrome associated with elevated elastin production by affected skin fibroblasts in culture.
    Giro MG; Duvic M; Smith LT; Kennedy R; Rapini R; Arnett FC; Davidson JM
    J Invest Dermatol; 1992 Aug; 99(2):129-37. PubMed ID: 1629625
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Buschke-Ollendorff Syndrome (connective tissue nevus and osteopoikilosis). Study of 7 familial cases].
    Grasa MP; Giménez H; Bosch R; Vega ML; Abascal M; Navarro F; Carapeto FJ
    Actas Dermosifiliogr; 1981; 72(11-12):565-70. PubMed ID: 7344431
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.